Trials / Completed
CompletedNCT04204876
Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Longitudinal imaging in patients with large vessel vasculitis to predict further disease course
Detailed description
This explorative longitudinal prospective observational study is to explore different aspects of vessel wall characteristics as detected by magnet resonance imaging (MRI) techniques and positron emission tomography/computer tomography (PET/CT) in patients with large vessel giant cell Arteriitis (LV-GCA) for their usefulness as predictive factor for future giant cell arteritis (GCA) relapse. It analyses parameters in PET/CT and MRI in patients with GCA at treatment stop which correlate with GCA relapse within the first 6 months after treatment stop. Patients included in the established local GCA database (BARK) will be screened for eligibility. Aortal imaging is performed during routine care according to established guidelines at diagnosis and during Follow Up at least every two years and before treatment stop.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Magnet Resonance Imaging (MRI) | MRI with and without Gadolinium contrast agent for the following vessels: thoracic aorta (ascending, arch, descending arch, left and right common carotic, subclavian, and vertebral artery) |
| DIAGNOSTIC_TEST | PET/CT analysis | Standard value uptake measurement (SUV) based on quantitative score normalized to liver (SUV vessel max/liver mean) at the following vessel regions: Carotid artery: common, internal, external; Subclavian artery; Axillary artery; Vertebral artery; Thoracic Aorta; Abdominal Aorta; Common femoral artery; Deep femoral artery; Popliteal artery |
Timeline
- Start date
- 2020-05-28
- Primary completion
- 2023-08-05
- Completion
- 2023-08-05
- First posted
- 2019-12-19
- Last updated
- 2024-01-18
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04204876. Inclusion in this directory is not an endorsement.